Taiwan
· Delayed Price · Currency is TWD Dr. Wu Skincare Statistics
Total Valuation
Dr. Wu Skincare has a market cap or net worth of TWD 6.13 billion. The enterprise value is 5.18 billion.
| Market Cap | 6.13B |
| Enterprise Value | 5.18B |
Important Dates
The last earnings date was Thursday, May 15, 2025.
| Earnings Date | May 15, 2025 |
| Ex-Dividend Date | Jul 3, 2025 |
Share Statistics
Dr. Wu Skincare has 45.05 million shares outstanding. The number of shares has increased by 0.25% in one year.
| Current Share Class | 45.05M |
| Shares Outstanding | 45.05M |
| Shares Change (YoY) | +0.25% |
| Shares Change (QoQ) | -0.62% |
| Owned by Insiders (%) | 25.65% |
| Owned by Institutions (%) | 0.87% |
| Float | 15.03M |
Valuation Ratios
The trailing PE ratio is 13.11.
| PE Ratio | 13.11 |
| Forward PE | n/a |
| PS Ratio | 4.94 |
| PB Ratio | 4.03 |
| P/TBV Ratio | 4.03 |
| P/FCF Ratio | 12.06 |
| P/OCF Ratio | 11.98 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 9.76, with an EV/FCF ratio of 10.21.
| EV / Earnings | 11.06 |
| EV / Sales | 4.18 |
| EV / EBITDA | 9.76 |
| EV / EBIT | 9.92 |
| EV / FCF | 10.21 |
Financial Position
The company has a current ratio of 3.76, with a Debt / Equity ratio of 0.03.
| Current Ratio | 3.76 |
| Quick Ratio | 3.28 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | 0.08 |
| Debt / FCF | 0.09 |
| Interest Coverage | 450.75 |
Financial Efficiency
Return on equity (ROE) is 30.58% and return on invested capital (ROIC) is 20.99%.
| Return on Equity (ROE) | 30.58% |
| Return on Assets (ROA) | 16.81% |
| Return on Invested Capital (ROIC) | 20.99% |
| Return on Capital Employed (ROCE) | 33.51% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.64 |
| Inventory Turnover | 2.11 |
Taxes
In the past 12 months, Dr. Wu Skincare has paid 116.36 million in taxes.
| Income Tax | 116.36M |
| Effective Tax Rate | 19.89% |
Stock Price Statistics
The stock price has decreased by -23.38% in the last 52 weeks. The beta is 0.06, so Dr. Wu Skincare's price volatility has been lower than the market average.
| Beta (5Y) | 0.06 |
| 52-Week Price Change | -23.38% |
| 50-Day Moving Average | 136.86 |
| 200-Day Moving Average | 147.09 |
| Relative Strength Index (RSI) | 43.75 |
| Average Volume (20 Days) | 34,450 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Dr. Wu Skincare had revenue of TWD 1.24 billion and earned 468.80 million in profits. Earnings per share was 10.37.
| Revenue | 1.24B |
| Gross Profit | 872.61M |
| Operating Income | 522.88M |
| Pretax Income | 585.16M |
| Net Income | 468.80M |
| EBITDA | 525.71M |
| EBIT | 522.88M |
| Earnings Per Share (EPS) | 10.37 |
Balance Sheet
The company has 985.86 million in cash and 44.35 million in debt, giving a net cash position of 941.51 million or 20.90 per share.
| Cash & Cash Equivalents | 985.86M |
| Total Debt | 44.35M |
| Net Cash | 941.51M |
| Net Cash Per Share | 20.90 |
| Equity (Book Value) | 1.52B |
| Book Value Per Share | 33.74 |
| Working Capital | 1.02B |
Cash Flow
In the last 12 months, operating cash flow was 511.28 million and capital expenditures -3.21 million, giving a free cash flow of 508.07 million.
| Operating Cash Flow | 511.28M |
| Capital Expenditures | -3.21M |
| Free Cash Flow | 508.07M |
| FCF Per Share | 11.28 |
Margins
Gross margin is 70.40%, with operating and profit margins of 42.18% and 37.82%.
| Gross Margin | 70.40% |
| Operating Margin | 42.18% |
| Pretax Margin | 47.21% |
| Profit Margin | 37.82% |
| EBITDA Margin | 42.41% |
| EBIT Margin | 42.18% |
| FCF Margin | 40.99% |
Dividends & Yields
This stock pays an annual dividend of 11.00, which amounts to a dividend yield of 8.09%.
| Dividend Per Share | 11.00 |
| Dividend Yield | 8.09% |
| Dividend Growth (YoY) | 10.00% |
| Years of Dividend Growth | 2 |
| Payout Ratio | 105.70% |
| Buyback Yield | -0.25% |
| Shareholder Yield | 7.87% |
| Earnings Yield | 7.65% |
| FCF Yield | 8.29% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on May 26, 2016. It was a forward split with a ratio of 1.5.
| Last Split Date | May 26, 2016 |
| Split Type | Forward |
| Split Ratio | 1.5 |
Scores
Dr. Wu Skincare has an Altman Z-Score of 13.18 and a Piotroski F-Score of 5.
| Altman Z-Score | 13.18 |
| Piotroski F-Score | 5 |